137 related articles for article (PubMed ID: 10390605)
1. Novel mycophenolic adenine bis(phosphonate)s as potential immunosuppressants.
Pankiewicz KW; Lesiak-Watanabe K; Watanabe KA; Malinowski K
Curr Med Chem; 1999 Jul; 6(7):629-34. PubMed ID: 10390605
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of a methylenebis(phosphonate) analogue of mycophenolic adenine dinucleotide: a glucuronidation-resistant MAD analogue of NAD.
Lesiak K; Watanabe KA; Majumdar A; Powell J; Seidman M; Vanderveen K; Goldstein BM; Pankiewicz KW
J Med Chem; 1998 Feb; 41(4):618-22. PubMed ID: 9484510
[TBL] [Abstract][Full Text] [Related]
3. Novel mycophenolic adenine bis(phosphonate) analogues as potential differentiation agents against human leukemia.
Pankiewicz KW; Lesiak-Watanabe KB; Watanabe KA; Patterson SE; Jayaram HN; Yalowitz JA; Miller MD; Seidman M; Majumdar A; Prehna G; Goldstein BM
J Med Chem; 2002 Jan; 45(3):703-12. PubMed ID: 11806722
[TBL] [Abstract][Full Text] [Related]
4. Probing binding requirements of type I and type II isoforms of inosine monophosphate dehydrogenase with adenine-modified nicotinamide adenine dinucleotide analogues.
Chen L; Gao G; Felczak K; Bonnac L; Patterson SE; Wilson D; Bennett EM; Jayaram HN; Hedstrom L; Pankiewicz KW
J Med Chem; 2007 Nov; 50(23):5743-51. PubMed ID: 17958343
[TBL] [Abstract][Full Text] [Related]
5. NAD-based inhibitors with anticancer potential.
Felczak K; Vince R; Pankiewicz KW
Bioorg Med Chem Lett; 2014 Jan; 24(1):332-6. PubMed ID: 24269162
[TBL] [Abstract][Full Text] [Related]
6. Cofactor-type inhibitors of inosine monophosphate dehydrogenase via modular approach: targeting the pyrophosphate binding sub-domain.
Felczak K; Chen L; Wilson D; Williams J; Vince R; Petrelli R; Jayaram HN; Kusumanchi P; Kumar M; Pankiewicz KW
Bioorg Med Chem; 2011 Mar; 19(5):1594-605. PubMed ID: 21324702
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxicity and cellular differentiation activity of methylenebis(phosphonate) analogs of tiazofurin and mycophenolic acid adenine dinucleotide in human cancer cell lines.
Yalowitz JA; Pankiewicz K; Patterson SE; Jayaram HN
Cancer Lett; 2002 Jul; 181(1):31-8. PubMed ID: 12430176
[TBL] [Abstract][Full Text] [Related]
8. Inhibitors of the IMPDH enzyme as potential anti-bovine viral diarrhoea virus agents.
Stuyver LJ; Lostia S; Patterson SE; Clark JL; Watanabe KA; Otto MJ; Pankiewicz KW
Antivir Chem Chemother; 2002 Nov; 13(6):345-52. PubMed ID: 12718406
[TBL] [Abstract][Full Text] [Related]
9. Novel methylenephosphophosphonate analogues of mycophenolic adenine dinucleotide. Inhibition of inosine monophosphate dehydrogenase.
Rejman D; Olesiak M; Chen L; Patterson SE; Wilson D; Jayaram HN; Hedstrom L; Pankiewicz KW
J Med Chem; 2006 Aug; 49(16):5018-22. PubMed ID: 16884314
[TBL] [Abstract][Full Text] [Related]
10. Bis(sulfonamide) isosters of mycophenolic adenine dinucleotide analogues: inhibition of inosine monophosphate dehydrogenase.
Chen L; Petrelli R; Olesiak M; Wilson DJ; Labello NP; Pankiewicz KW
Bioorg Med Chem; 2008 Aug; 16(15):7462-9. PubMed ID: 18583139
[TBL] [Abstract][Full Text] [Related]
11. The structure of inosine 5'-monophosphate dehydrogenase and the design of novel inhibitors.
Sintchak MD; Nimmesgern E
Immunopharmacology; 2000 May; 47(2-3):163-84. PubMed ID: 10878288
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationships for inhibition of inosine monophosphate dehydrogenase and differentiation induction of K562 cells among the mycophenolic acid derivatives.
Mitsuhashi S; Takenaka J; Iwamori K; Nakajima N; Ubukata M
Bioorg Med Chem; 2010 Nov; 18(22):8106-11. PubMed ID: 20934342
[TBL] [Abstract][Full Text] [Related]
13. Dual inhibitors of inosine monophosphate dehydrogenase and histone deacetylases for cancer treatment.
Chen L; Wilson D; Jayaram HN; Pankiewicz KW
J Med Chem; 2007 Dec; 50(26):6685-91. PubMed ID: 18038969
[TBL] [Abstract][Full Text] [Related]
14. Determination of inosine monophosphate dehydrogenase activity in human CD4+ cells isolated from whole blood during mycophenolic acid therapy.
Vethe NT; Bergan S
Ther Drug Monit; 2006 Oct; 28(5):608-13. PubMed ID: 17038874
[TBL] [Abstract][Full Text] [Related]
15. Mycophenolic acid and thiazole adenine dinucleotide inhibition of Tritrichomonas foetus inosine 5'-monophosphate dehydrogenase: implications on enzyme mechanism.
Hedstrom L; Wang CC
Biochemistry; 1990 Jan; 29(4):849-54. PubMed ID: 1971185
[TBL] [Abstract][Full Text] [Related]
16. Triazole-linked inhibitors of inosine monophosphate dehydrogenase from human and Mycobacterium tuberculosis.
Chen L; Wilson DJ; Xu Y; Aldrich CC; Felczak K; Sham YY; Pankiewicz KW
J Med Chem; 2010 Jun; 53(12):4768-78. PubMed ID: 20491506
[TBL] [Abstract][Full Text] [Related]
17. Novel nicotinamide adenine dinucleotide analogues as potential anticancer agents: quest for specific inhibition of inosine monophosphate dehydrogenase.
Pankiewicz KW
Pharmacol Ther; 1997; 76(1-3):89-100. PubMed ID: 9535171
[TBL] [Abstract][Full Text] [Related]
18. Species-specific inhibition of inosine 5'-monophosphate dehydrogenase by mycophenolic acid.
Digits JA; Hedstrom L
Biochemistry; 1999 Nov; 38(46):15388-97. PubMed ID: 10563825
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous quantification of IMPDH activity and purine bases in lymphocytes using LC-MS/MS: assessment of biomarker responses to mycophenolic acid.
Vethe NT; Ali AM; Reine PA; Andersen AM; Bremer S; Line PD; Rootwelt H; Bergan S
Ther Drug Monit; 2014 Feb; 36(1):108-18. PubMed ID: 24061448
[TBL] [Abstract][Full Text] [Related]
20. Structure and mechanism of inosine monophosphate dehydrogenase in complex with the immunosuppressant mycophenolic acid.
Sintchak MD; Fleming MA; Futer O; Raybuck SA; Chambers SP; Caron PR; Murcko MA; Wilson KP
Cell; 1996 Jun; 85(6):921-30. PubMed ID: 8681386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
